26
Sep 2024
Why Transparency Can’t Guarantee Market Justice: The Case of Pharmaceuticals
The controversies surrounding the heavily redacted contracts between the European Commission and COVID-19 vaccine producers have highlighted ‘transparency’ as a hotly debated concept in the European pharmaceutical market, but calls for more transparency are also heard frequently in other markets, including, most recently, in those involving AI technologies.
Read more →
